Search

Pui N Seto

from San Carlos, CA
Age ~68
Get Report
Also known as:
Michael Seto, Mike Seto
Phone and address:
292 Clifton Ave, San Carlos, CA 94070
(650) 593-2115
Related to:
Justin G Lavallee, 26Andy G Wong, 45Nina Seto, 67Jeanne Kum, 62David S Kum, 65Mimi Lee Kum, 66Yvonne Kum, 60Nicholas K Seto, 34
Connected to:
Alberta V Seto, 86Alex C Seto, 42Anita C Seto, 79Annie G Seto, 75Connie L Seto, 68Daniel S Seto, 61Dewey V Seto, 53Diella Seto, 39Erika Seto, 34Jin C Seto, 61

Pui Seto Phones & Addresses

  • 292 Clifton Ave, San Carlos, CA 94070 (650) 593-2115
  • Union City, CA
  • Daly City, CA
  • 292 Clifton Ave, San Carlos, CA 94070 (415) 831-1543

Work

Position: Professional/Technical

Education

Degree: Associate degree or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Pui Seto
President
MAHAPARINIRVANA DHARMA & MEDITATION CENTER
19 Prague St, San Francisco, CA 94112

Publications

Us Patents

Psma Targeting Trispecific Proteins And Methods Of Use

View page
US Patent:
20210095047, Apr 1, 2021
Filed:
Oct 16, 2020
Appl. No.:
17/072370
Inventors:
- South San Francisco CA, US
Jeanmarie GUENOT - San Francisco CA, US
Holger WESCHE - San Francisco CA, US
Robert B. DUBRIDGE - Belmont CA, US
Bryan D. LEMON - Mountain View CA, US
Richard J. AUSTIN - San Francisco CA, US
Pui SETO - San Carlos CA, US
International Classification:
C07K 16/30
C07K 16/28
A61P 35/00
C07K 16/18
Abstract:
Provided herein are prostate specific membrane antigen (PSMA) targeting trispecific proteins comprising a domain binding to CD3, a half-life extension domain, and a domain binding to PSMA. Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such PSMA targeting trispecific proteins. Also disclosed are methods of using the disclosed PSMA targeting trispecific proteins in the prevention, and/or treatment diseases, conditions and disorders.

Single Chain Variable Fragment Cd3 Binding Proteins

View page
US Patent:
20200231672, Jul 23, 2020
Filed:
Jan 27, 2020
Appl. No.:
16/773806
Inventors:
- South San Francisco CA, US
Pui SETO - San Carlos CA, US
Richard J. AUSTIN - San Francisco CA, US
Luke EVNIN - San Francisco CA, US
Jeanmarie GUENOT - San Francisco CA, US
Bryan LEMON - Mountain View CA, US
International Classification:
C07K 16/28
C07K 16/18
Abstract:
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.

Prostate Specific Membrane Antigen Binding Protein

View page
US Patent:
20180161428, Jun 14, 2018
Filed:
Nov 22, 2017
Appl. No.:
15/821498
Inventors:
- South San Francisco CA, US
Pui SETO - San Carlos CA, US
Patrick BAEUERLE - Gauting, DE
Jeanmarie GUENOT - San Francisco CA, US
Holger WESCHE - San Francisco CA, US
Bryan D. LEMON - Mountain View CA, US
Richard J. AUSTIN - San Francisco CA, US
International Classification:
A61K 39/395
A61K 38/17
A61P 35/00
Abstract:
Disclosed herein are PSMA binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a PSMA binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are further provided.

Psma Targeting Trispecific Proteins And Methods Of Use

View page
US Patent:
20180162949, Jun 14, 2018
Filed:
Nov 22, 2017
Appl. No.:
15/821530
Inventors:
- South San Francisco CA, US
Jeanmarie GUENOT - San Francisco CA, US
Holger WESCHE - San Francisco CA, US
Robert B. DUBRIDGE - Belmont CA, US
Bryan D. LEMON - Mountain View CA, US
Richard J. AUSTIN - San Francisco CA, US
Pui SETO - San Carlos CA, US
International Classification:
C07K 16/30
C07K 16/28
A61P 35/00
Abstract:
Provided herein are prostate specific membrane antigen (PSMA) targeting trispecific proteins comprising a domain binding to CD3, a half-life extension domain, and a domain binding to PSMA. Also provided are pharmaceutical compositions thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such PSMA targeting trispecific proteins. Also disclosed are methods of using the disclosed PSMA targeting trispecific proteins in the prevention, and/or treatment diseases, conditions and disorders.

Single Chain Variable Fragment Cd3 Binding Proteins

View page
US Patent:
20170369575, Dec 28, 2017
Filed:
Sep 14, 2017
Appl. No.:
15/704620
Inventors:
- South San Francisco CA, US
Pui SETO - San Carlos CA, US
Richard J. AUSTIN - San Francisco CA, US
Luke EVNIN - San Francisco CA, US
Jeanmarie GUENOT - San Francisco CA, US
Bryan D. LEMON - Mountain View CA, US
International Classification:
C07K 16/28
Abstract:
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.

Single Chain Variable Fragment Cd3 Binding Proteins

View page
US Patent:
20170334997, Nov 23, 2017
Filed:
May 19, 2017
Appl. No.:
15/600264
Inventors:
- South San Francisco CA, US
Pui SETO - San Carlos CA, US
Richard J. AUSTIN - San Francisco CA, US
Luke EVNIN - San Francisco CA, US
Jeanmarie GUENOT - San Francisco CA, US
Bryan D. LEMON - Mountain View CA, US
International Classification:
C07K 16/28
Abstract:
Disclosed herein are single chain variable fragment CD3 binding proteins with improved binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single chain variable fragment CD3 binding protein according to the instant disclosure. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are provided.
Control profile
Pui N Seto from San Carlos, CA, age ~68 Get Report